首頁 › 肺癌 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 肺癌 臨床試驗
36 項針對 肺癌 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- ECOG-ACRIN Cancer Research Group, Philadelphia
- Lankenau Medical Center, Wynnewood · 距離 7 英里
- Riddle Memorial Hospital, Media · 距離 12 英里
- 還有 2 項
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
- 還有 5 項
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
招募中3 期
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · 距離 7 英里
- Riddle Memorial Hospital, Media · 距離 12 英里
- 還有 1 項
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 距離 22 英里
Empathic Communication Skills (ECS) Training
招募中歡迎健康志工
- University of Pennsylvania (Data Collection Only), Philadelphia
- Fox Chase Cancer Center (Data Collection Only), Philadelphia
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Lankenau Medical Center, Wynnewood · 距離 7 英里
- 還有 2 項
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
招募中3 期
- Alliance Cancer Specialists - Media, Media · 距離 12 英里
A Registry for People With Lung Cancer
招募中觀察性研究
- Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
招募中2/3 期
- Hospital of the University of Pennsylvania, Philadelphia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
- USO - Alliance Cancer Specialists, PC, Horsham · 距離 16 英里
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Philadelphia
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
招募中3 期
- Fox Chase Cancer Center, Philadelphia
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
招募中3 期
- Hospital of the University of Pennsylvania, Philadelphia
Pemefolacianine for IMI of Lung Cancer
招募中1 期
- University of Pennsylvania, Philadelphia
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
招募中2 期
- Abramson Cancer Center ( Site 0010), Philadelphia
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
招募中3 期
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- 還有 5 項
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
招募中1 期
- Sidney Kimmel Cancer Center, Philadelphia
MOv19-BBz CAR T Cells in FRa+ Cancers
招募中1 期
- University of Pennsylvania, Philadelphia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · 距離 8 英里
Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
招募中
- Penn Medicine University City, Philadelphia
- Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine Washington Square, Philadelphia
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
招募中歡迎健康志工
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
招募中
- Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
招募中2 期
- Fox Chase Cancer Center, Philadelphia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · 距離 8 英里
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
招募中2 期
- Fox Chase Cancer Center, Philadelphia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer
招募中2 期
- University of Pennsylvania, Philadelphia
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- Fox Chase Cancer Center, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- University of Pennsylvania, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
招募中
- Thomas Jefferson University Hospital, Philadelphia
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
招募中
- Jefferson Health Northeast, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Abington Memorial Hospital, Abington · 距離 12 英里
- 還有 1 項
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
招募中觀察性研究
- Christiana Care Health System-Wilmington Hospital, Wilmington · 距離 25 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Philadelphia
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
招募中觀察性研究
- Temple University, Philadelphia
其他城市的 肺癌 試驗
- Houston, TX78 項研究
- Boston, MA62 項研究
- New York City, NY60 項研究
- Los Angeles, CA45 項研究
- Arlington, VA41 項研究
- Washington, DC41 項研究
- Chicago, IL41 項研究
- Nashville, TN40 項研究
- Baltimore, MD40 項研究
- St. Louis, MO39 項研究
- Columbus, OH37 項研究
- Seattle, WA33 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 前列腺癌44 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
- 胰臟癌26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。